8301 - 8325 of 9145 Results
Title
Year
-
OPENTitle: The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 7Start Page: 3158End Page: 3170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12966Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12966Citation Count: 30
- Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic Proteins2018RESTRICTEDTitle: Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic ProteinsJournal Name: Methods in Molecular BiologyPublisher: Springer New YorkVol:Issue #:Start Page: 369End Page: 386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-4939-7811-3_24Citation Count: 20
-
OPENTitle: MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 7Start Page: 670End Page: 672Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820c30c1Best OA location URL: http://n.neurology.org/content/neurology/76/7/670.full.pdfCitation Count: 75
- Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure2011OPENTitle: Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposureJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 15Start Page: 1296End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182152830Best OA location URL: https://n.neurology.org/content/neurology/76/15/1296.full.pdfCitation Count: 84
- Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neurons2010RESTRICTEDTitle: Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neuronsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 45Issue #: 4Start Page: 324End Page: 334Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2010.07.004Citation Count: 23
- Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease2018RESTRICTEDTitle: Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative diseaseJournal Name: Current Opinion in ToxicologyPublisher: Elsevier BVVol: 7Issue #:Start Page: 127End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cotox.2018.02.003Citation Count: 21
- Therapeutic directions for Parkinson's disease2010RESTRICTEDTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S152End Page: 4Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Citation Count: 7
- A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease2011OPENTitle: A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 45Issue #: 1Start Page: 305End Page: 309Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.08.014Best OA location URL: https://doaj.org/article/8397958fd01c42e88c4c7413fd99d7ceCitation Count: 137
- Serotonergic mediated body mass index changes in Parkinson's disease2011RESTRICTEDTitle: Serotonergic mediated body mass index changes in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 43Issue #: 3Start Page: 609End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009Citation Count: 44
- Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex2012RESTRICTEDTitle: Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complexJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 242End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.05.017Citation Count: 42
-
OPENTitle: Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 26Issue #: 23Start Page: 11564End Page: 11564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms262311564Best OA location URL: https://www.mdpi.com/1422-0067/26/23/11564/pdf?version=1764581678Citation Count: 1
- Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson’s disease: the SPIN-PD study2015RESTRICTEDTitle: Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson’s disease: the SPIN-PD studyJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 9Issue #: 2Start Page: 89End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.14.103Citation Count: 5
- Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers2015RESTRICTEDTitle: Clinical and imaging markers in premotor LRRK2 G2019S mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1170End Page: 1176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.007Citation Count: 42
- Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats2015RESTRICTEDTitle: Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 569End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.016Citation Count: 50
- Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease2016RESTRICTEDTitle: Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 19End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.07.005Citation Count: 33
-
OPENTitle: Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive ImpairmentJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 8Start Page: 643End Page: 649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac042Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9297096Citation Count: 15
-
OPENTitle: LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104626End Page: 104626Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104626Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104626Citation Count: 102
- Brain activation pattern related to gait disturbances in Parkinson's disease2012RESTRICTEDTitle: Brain activation pattern related to gait disturbances in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1498End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25139Citation Count: 53
- Teaching program for the Unified Dyskinesia Rating Scale2009RESTRICTEDTitle: Teaching program for the Unified Dyskinesia Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 9Start Page: 1296End Page: 1298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22563Citation Count: 12
-
OPENTitle: The deterministic role of 5-mers in microRNA-gene targetingJournal Name: RNA BiologyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2018.1462652Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2018.1462652?needAccess=trueCitation Count: 16
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 18
- Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics2005RESTRICTEDTitle: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinicsJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 4Start Page: 519End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20751Citation Count: 0
- Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 35
-
OPENTitle: Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 89Issue #: 3Start Page: 398End Page: 406Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2011.08.009Best OA location URL: http://www.cell.com/article/S0002929711003594/pdfCitation Count: 303
-
OPENTitle: Precise disease heterogeneity and progression quantification in MSA and Parkinson’s disease using machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-026-45949-5Best OA location URL: https://www.nature.com/articles/s41598-026-45949-5_reference.pdfCitation Count: 0